UNSPSC 51391502: Isoxaprolol

This classification denotes a bronchodilator and beta-adrenergic blocking agent with the molecular formula C19H26N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0Y84EU1HAA, chemically known as 2-propanol, 1-((1,1-dimethylethyl)amino)-3-(2-(2-(3-methyl-5-isoxazolyl)ethenyl)phenoxy)- but generally known as isoxaprolol, which bears US NIH Compound Identifier 6443854. European Medicines Agency schedules Isoxaprolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08342MIG.

UNSPSC 51391502 Isoxaprolol is a Commodity code that does not reflect the actual work state and local governments are soliciting under this classification. The recent opportunities tagged to this code show a mismatch: Seminole County, Florida has issued an IFB for naloxone and drug deactivation systems, and the Texas Health and Human Services Commission has posted an RFI regarding direct-to-manufacturer prescription programs. Neither solicitation involves isoxaprolol or related pharmaceutical manufacturing. The code shows minimal relevant recent activity, and the tagged opportunities appear to reflect broader pharmaceutical procurement or opioid-response inventory rather than the specific drug compound this code nominally covers.

No current market activity supports targeting this code for business development. Vendors should monitor whether additional opportunities emerge under this Commodity code or whether state and local procurement offices retag pharmaceutical or opioid-response solicitations to more appropriate classifications. The geographic presence of Seminole County in Florida and the Texas HHS Commission suggests these states maintain active health and human services procurement, but the current tagging makes this code an unreliable signal for pursuing related work.